June 21, 2016

NorthMarq Capital's Cincinnati office arranges $2.6 million refinance for Kedrion Biopharma in Rock Hill, South Carolina

Kedrion Biopharma

Debt & Equity

Multi-Tenant

CINCINNATI (June 21, 2016) – Susan Branscome, senior vice president of NorthMarq Capital’s Cincinnati-based regional office, arranged refinancing of $2,600,000 for Kedrion Biopharma, a 13,000 sq. ft. medical property located at 1843 Cherry Road, Rock Hill, South Carolina. The transaction was structured with a 20-year term, 20-year amortization schedule and financed by Symetra Financial. KEDplasma represents the property’s major tenant. “Susan Branscome and her team met our financing goals and closed the deal. Susan closes all of our permanent loans; she finds the best financing options and always gets the job done,” said Michael H. Stough, President and CEO, The Stough Group, which owns the asset.

Available Medical Office properties

Northmarq is a full-service capital markets resource for commercial real estate investors, offering seamless collaboration with top experts in debt, equity, investment sales, loan servicing, and fund management. The company combines industry-leading capabilities with a flexible structure, enabling its national team of experienced professionals to create innovative solutions for clients. Northmarq's solid foundation and entrepreneurial approach have built an annual transaction volume of more than $39 billion and a loan servicing portfolio of more than $76 billion. Through the 2022 acquisition of Stan Johnson Company and Four Pillars Capital Markets, Northmarq established itself as a provider of opportunities across all major asset classes. For more information, visit: www.northmarq.com.